• Home
  • >
  • Ipca Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/ipca-laboratories-ltd.png Logo

Ipca Laboratories Ltd Financial Statement

Ipca Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue1,523.721,698.811,529.5
Operating Expense1,233.341,353.691,188.81
Net Profit136.94162.13166.58
Net Profit Margin8.999.5410.89
Earning Per Share5.46.396.57
EBIDTA289.27346.12337.69
Effective Tax Rate21.3924.3423.48

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Ipca Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual6,244.325,829.795,419.99
Operating Expenses Annual5,317.554,520.533,875.64
Operating Profit Annual1,052.391,375.831,607.19
Interest Annual45.547.699.04
Depreciation236.19212.2192.31
Net Profit Annual471.32884.081,140.01
Tax Annual253.36224.77240.14

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Ipca Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning990.93559.01295.39
Cash Flow from Operations805.81856.071,090.13
Cash Flow from Investing-725-850.93-520.69
Cash Flow from Financing507.24426.78-305.82
Cash Flow at the End1,578.98990.93559.01

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Ipca Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)16.923.6629.71
PBIT Margin (%)12.7119.6725.85
PBT Margin (%)12.4317.7923.63
Net PROFIT Margin (%)8.715.8222.2
Return On Networth / Equity (%)8.717.9227.59
Return On Networth /Employed(%)11.5920.2630.56
Return On Assets (%)7.8316.1426.19
Total Debt / Equity(X)0.20.10.08
Asset Turnover Ratio (%)0.91.021.18

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Ipca Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual2,769.642,414.772,123.59
Total Current Assets Annual5,189.274,446.713,436.96
Non Current Assets Annual3,437.163,166.362,631.4
Total Shareholders Funds Annual5,842.025,464.844,701.65
Total Assets Annual8,626.437,623.536,068.36

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Ipca Laboratories Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Ipca Laboratories Ltd has a market capitalization of 20,557.65 Cr. Value Research classifies it as a Large-Cap company.

Yes, Ipca Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.25.

In FY 2023, Ipca Laboratories Ltd recorded a total revenue of approximately 6,244.32 Cr marking a significant milestone in the company's financial performance.

Ipca Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Ipca Laboratories Ltd's current PE ratio is 43.62.

Ipca Laboratories Ltd's ROCE averaged 19.1% from the FY ending March 2021 to 2023, with a median of 18.2%. It peaked at 28.1% in March 2021, reflecting strong capital efficiency over the period..

Ipca Laboratories Ltd's latest EBIT is Rs. 790.83 Cr, surpassing the average EBIT of Rs. 1,110.75 Cr over the 5 years..